PURCHASE ORDER
Active75F40126P00309
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$283.4K
obligated · signed 2 months ago
"EO 14398" AGILENT 9500 ICP-QQQ BUNDLE
Performance timeline
Start
Sep 10, 2026
Potential end
Dec 7, 2029
with all options
Loading status
Estimated start: Dec 7, 2028
AGILENT TECHNOLOGIES INC
Contract 75F40126P00309
UEI
SD9JZ9S7MEA6
Parent Company
AGILENT TECHNOLOGIES, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 00
Current Obligation
$283,395
Base + Exercised Options
$283,395
Total Ceiling Value
$336,132
Contract Type
FIRM FIXED PRICE
NAICS
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Place of Performance
Congressional District: 00
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.